Adage Capital Partners
ENTL

Adage Capital Partners’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Adage Capital Partners’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-827,200
Closed -$15.3M – 784
2017
Q3 		$15.3M Sell
827,200
-63,080
-7% -$1.09M 0.04% 479
2017
Q2 		$14.7M Buy
+890,280
New +$12.4M 0.04% 487
2016
Q2 		– Sell
-200,000
Closed -$3.64M – 746
2016
Q1 		$3.64M Sell
200,000
-66,630
-25% -$1.08M 0.01% 619
2015
Q4 		$4.5M Buy
+266,630
New +$4.53M 0.01% 608

Other funds holding ENTL

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $383M AUM 123.08% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Adage Capital Partners's ENTL Position: Q4 2017 in Review

Adage Capital Partners sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 827,200 shares — an estimated $15.3M sold.

Adage Capital Partners first reported a position in ENTL in Q4 2015 and held it in 4 quarters. The position peaked at $15.3M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Adage Capital Partners reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Adage Capital Partners sold 827,200 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $15.3M.
  • Adage Capital Partners first reported a position in Entellus Medical, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
  • Adage Capital Partners's Entellus Medical, Inc. Common Stock position peaked at $15.3M in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Adage Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.